According to Fortune Business Insights, the global mammography market was valued at USD 13.86 billion in 2025. The market is projected to grow from USD 14.31 billion in 2026 to USD 19.37 billion by 2034, registering a CAGR of 3.9% during 2026–2034. North America dominated the market with a 73.09% share in 2025. Mammography is a medical imaging technique used to detect, diagnose, and monitor breast abnormalities, particularly breast cancer. Increasing breast cancer incidence, greater awareness of early detection, and expanding screening programs are supporting market growth. Technological advancements in digital imaging, 3D breast tomosynthesis, and artificial intelligence (AI) are further improving diagnostic capabilities. 

Key Market Trends

The adoption of AI-enabled 3D digital breast tomosynthesis (DBT) is a major trend in the mammography market. Unlike conventional two-dimensional imaging, DBT captures multiple images from different angles, providing improved visualization of breast tissue and reducing tissue overlap. This technology is particularly useful for examining women with dense breast tissue.

AI-assisted image interpretation is also gaining importance. These systems help radiologists identify suspicious lesions, prioritize complex cases, and improve workflow efficiency. In April 2026, GE HealthCare expanded its collaboration with DeepHealth to commercialize AI-powered mammography solutions globally, combining breast imaging software with advanced imaging systems.

Get a Free Sample PDF - https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/mammography-market-118257

Market Growth Drivers

The expansion of organized breast cancer screening programs is a primary driver of market growth. Governments, healthcare organizations, and cancer societies are promoting routine mammography examinations to facilitate early diagnosis and reduce breast cancer mortality. Increasing public awareness, improved screening infrastructure, and supportive reimbursement policies are encouraging more women to undergo screening.

The rising incidence of breast cancer is another significant factor. Early detection enables healthcare professionals to identify abnormalities and initiate appropriate treatment sooner. Growing investments in diagnostic imaging facilities and increasing adoption of advanced mammography technologies are further supporting market expansion. Personalized screening approaches based on breast density, family history, genetic predisposition, and AI-assisted risk assessment are also creating new opportunities. 

Market Segmentation

By service, the market is divided into screening mammography services, diagnostic mammography services, and mammography-guided interventional services. Screening mammography services dominated the market in 2025, supported by preventive healthcare initiatives, routine screening recommendations, and increasing awareness of early breast cancer detection. Mammography-guided interventional services are projected to grow at a CAGR of 5.9% during the forecast period.

By imaging modality, the market includes 2D digital mammography services, 3D digital breast tomosynthesis services, contrast-enhanced mammography services, and others. 3D digital breast tomosynthesis held a 50.6% share in 2025, driven by improved visualization, enhanced detection capabilities, and reduced false-positive recalls. Contrast-enhanced mammography services are expected to grow at a CAGR of 5.3%.

By end user, the market is segmented into hospitals, specialty clinics, diagnostic centers, and others. Hospitals dominated the market in 2025 because they provide comprehensive breast cancer care, including screening, diagnostic imaging, biopsies, surgery, and oncology services. The hospital segment is projected to account for 43.9% of the market in 2026. Specialty clinics are expected to grow at a CAGR of 4.5%. 

Regional Analysis

North America dominated the global mammography market, reaching USD 10.13 billion in 2025. The region benefits from advanced healthcare infrastructure, established reimbursement systems, and widespread adoption of modern breast imaging technologies. The U.S. market is projected to reach USD 10.11 billion in 2026, accounting for approximately 70.6% of global revenue.

Europe is projected to reach USD 2.13 billion in 2026, registering a CAGR of 3.9%. Organized population-based screening programs, advanced diagnostic facilities, and government support for early detection are supporting regional demand. Germany is expected to reach USD 0.40 billion, while the U.K. market is projected to reach USD 0.24 billion in 2026.

Asia Pacific is expected to reach USD 1.18 billion in 2026, becoming the third-largest regional market. Increasing breast cancer incidence, rising healthcare expenditure, and improvements in diagnostic infrastructure are supporting growth. China is projected to reach USD 0.51 billion, Japan USD 0.33 billion, and India USD 0.08 billion in 2026. Latin America is expected to reach USD 0.34 billion, while the Gulf Cooperation Council market is projected to reach USD 0.08 billion. 

Market Challenges

High acquisition and maintenance costs remain significant restraints. Advanced digital mammography systems, 3D tomosynthesis equipment, contrast-enhanced imaging platforms, and AI software require substantial investment. These costs can limit adoption among smaller hospitals and rural diagnostic centers, particularly in low- and middle-income countries.

A shortage of skilled breast imaging professionals presents another challenge. The growing volume of mammography examinations increases demand for experienced radiologists and trained technologists. Workforce shortages can delay reporting, reduce screening efficiency, and affect access to timely diagnosis. 

Competitive Landscape

The market has a semi-consolidated competitive structure. Major players identified by Fortune Business Insights include RadNet, Inc., InHealth Group, SimonMed Imaging, Akumin Inc., Fortis Healthcare Ltd., Affidea Group, Unilabs, Evidia Group, and I-MED Radiology Network. These companies focus on expanding diagnostic services, adopting advanced imaging technologies, and establishing strategic collaborations to improve access and operational efficiency. 

Market Outlook

The mammography market is expected to grow steadily through 2034 as breast cancer screening programs expand and healthcare providers adopt advanced imaging technologies. AI-assisted interpretation, 3D tomosynthesis, and personalized screening strategies will create additional opportunities. Despite equipment costs and workforce shortages, the market is projected to increase from USD 14.31 billion in 2026 to USD 19.37 billion by 2034.